We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Cannabis Has Potential as Treatment for Common Movement Disorder

Phase I/II clinical trial will be first of its kind to explore cannabis as a potential treatment option for essential tremor.

Read More

How Effective is Responsible Vendor Training for Cannabis Retailers?

To date, 6 U.S. states have implemented retail sales of recreational marijuana but none have been able to implement an effective training program for retailers.

Read More

Setting Standards for Cannabis Extraction

Standards are needed to ensure products come from a clean, legal source, are properly tested and any claims made on their labels are evidenced.

Read More

Low Cost Cannabis-based Pain Patch Released

The developer of the technology claims that the safe, comfortable patch could help curb opioid abuse and addiction whilst effectively treating pain.

Read More

Cannabis Users May Experience ‘Noisy Brain’ During Rest

Cannabis users experience increased cortical activation during the brain’s resting state when compared with nonusers which may impair brain activity and disrupt cognitive processes.

Read More

Keystone Labs Receives Health Canada Approval

Keystone is now able to manufacture, process, package, label, and sell cannabis-related products.

Read More

Prenatal Exposure to Cannabis Impacts Sociability of Male Offspring Only

Study reveals sex-specific effects of prenatal cannabinoid exposure on adult offspring and identifies potential new therapeutic strategies.

Read More

A2LA Announces Partnership with American Trade Association for Cannabis and Hemp

A2LA will now work with ATACH to promote open-source quality management standards for the cannabis and hemp industries.

Read More

Canadian Clinicians Call for More Trials on Childhood Cannabinoid Consumption

Experts say that Canadian parents use unregulated cannabinoids for seizure control in children with neurologic conditions like epilepsy, and clinical trials are needed to inform doctors and parents on prescribing.

Read More

Maintaining Compliance with California’s Cannabis Pesticide Regulations

Failing to comply with the standards in place puts a cannabis company at risk of litigation and jeopardizes business contracts with other downstream cannabis operators.

Read More

Advertisement